Fig. 3From: Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriersSchematic illustration of graphene oxide (GO) functionalization with octaarginine (R8) and anti-HER2 antibody. Notes: Adapted from Wang X, Sun Q, Cui C, Li J, Wang Y. Anti-HER2 functionalized graphene oxide as a survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo. Drug Des Devel Ther. 2018;12:2841–2855 [127]Back to article page